Journal: Journal of Gastrointestinal Oncology
Article Title: TRNP1 regulates tumorigenesis and enhances immunotherapy response via c-Kit/STAT3 signaling in hepatocellular carcinoma
doi: 10.21037/jgo-2025-1-1084
Figure Lengend Snippet: TRNP1 knockdown enhances the therapeutic response of HCC to PD-1 blockade. (A) The correlation between the gene expression of TRNP1 and PDCD1 in human HCC samples using the GEPIA web tool. (B) Western blot images (left) and quantitative analysis (right) of TRNP1 knockdown in Hepa 1-6 cells are shown below. The representative images (C), tumor weight (D) and tumor growth (E) of xenograft tumors from Hepa 1-6 cells with NC and sh TRNP1 with/without anti-PD-1. (F) Lollipop graph illustrates the correlation between immune infiltration and TRNP1 expression. (G) The proportion of M1 and M2 macrophages in NC and TRNP1 knockdown Hepa 1–6 subcutaneous tumors was detected by flow cytometry, along with statistical data. (H) Volcano plot of ANXA1 expression in Sk-hep1 cells with or without TRNP1 knockdown. q-PCR (I) and ELISA (J) analyses show the expression of ANXA1 in mouse subcutaneous tumor tissues. ns, P>0.05; *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001. ANXA1, annexin A1; ELISA, enzyme-linked immunosorbent assay; GAPDH, glyceraldehyde 3-phosphate dehydrogenase; GEPIA, Gene Expression Profiling Interactive Analysis; HCC, hepatocellular carcinoma; NC, negative control; PD-1, programmed cell death protein 1; q-PCR, quantitative real-time polymerase chain reaction; TRNP1 , TMF1-regulated nuclear protein 1.
Article Snippet: In this study, the human HCC cell lines Sk-hep1, Hep3B, and HepG2 were obtained from the American Type Culture Collection (ATCC).
Techniques: Knockdown, Clinical Proteomics, Gene Expression, Western Blot, Expressing, Flow Cytometry, Enzyme-linked Immunosorbent Assay, Negative Control, Real-time Polymerase Chain Reaction